Enveric Biosciences Stock Today
| ENVB Stock | USD 0.90 0.04 4.65% |
Performance3 of 100
| Odds Of DistressLess than 19
|
Enveric Biosciences is trading at 0.9 as of the 24th of April 2024, a 4.65 percent increase since the beginning of the trading day. The stock's open price was 0.86. Enveric Biosciences has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Enveric Biosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 24th of June 2015 | Category Healthcare | Classification Health Care |
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Enveric Biosciences, Inc. is headquartered in Naples, Florida. Enveric Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 7.29 M outstanding shares of which 254.87 K shares are currently shorted by private and institutional investors with about 0.02 trading days to cover. More on Enveric Biosciences
Moving against Enveric Stock
| 0.41 | ITCI | Intracellular Th Financial Report 2nd of May 2024 | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Financial Report 20th of May 2024
Enveric Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Enveric Biosciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Enveric Biosciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Enveric Biosciences report their recommendations after researching Enveric Biosciences' financial statements, talking to executives and customers, or listening in on Enveric Biosciences' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Enveric Biosciences. The Enveric consensus assessment is calculated by taking the average forecast from all of the analysts covering Enveric Biosciences. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Enveric Biosciences' liquidity, profitability, solvency, and operating efficiency, Enveric Biosciences is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Enveric Biosciences is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Enveric Biosciences' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Enveric Biosciences' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Enveric Biosciences' financial leverage. It provides some insight into what part of Enveric Biosciences' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Enveric Biosciences (ENVB) is traded on NASDAQ Exchange in USA. It is located in 4851 Tamiami Trail N, Naples, FL, United States, 34103 and employs 7 people. Enveric Biosciences is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Enveric Biosciences's market, we take the total number of its shares issued and multiply it by Enveric Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Enveric Biosciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 7.29 M outstanding shares of which 254.87 K shares are currently shorted by private and institutional investors with about 0.02 trading days to cover.
Enveric Biosciences currently holds about 18.01 M in cash with (14.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.44, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Enveric Biosciences Probability Of Bankruptcy
Ownership AllocationEnveric Biosciences retains a total of 7.29 Million outstanding shares. Enveric Biosciences shows 7.0 percent of its outstanding shares held by insiders and 6.7 percent owned by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Enveric Ownership Details
Enveric Stock Price Odds Analysis
What are Enveric Biosciences' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Enveric Biosciences jumping above the current price in 90 days from now is about 69.98%. The Enveric Biosciences probability density function shows the probability of Enveric Biosciences stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.9017 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Enveric Biosciences will likely underperform. Additionally, enveric Biosciences has an alpha of 0.0513, implying that it can generate a 0.0513 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Enveric Biosciences to move above the current price in 90 days from now is about 69.98 (This Enveric Biosciences probability density function shows the probability of Enveric Stock to fall within a particular range of prices over 90 days) .
Enveric Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Enveric Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Enveric Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Enveric Biosciences' value.| Instituion | Recorded On | Shares | |
| Org Partners Llc | 2023-12-31 | 10.0 | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.0 | |
| Acadian Asset Management Llc | 2023-12-31 | 0.0 | |
| Royal Bank Of Canada | 2023-09-30 | 0.0 | |
| The Toronto-dominion Bank | 2023-12-31 | 0.0 | |
| Citadel Advisors Llc | 2023-09-30 | 0.0 | |
| Renaissance Technologies Corp | 2023-09-30 | 0.0 | |
| Armistice Capital, Llc | 2023-12-31 | 273 K | |
| Advisorshares Investments, Llc | 2023-12-31 | 141.8 K | |
| Blackrock Inc | 2023-12-31 | 29.6 K | |
| Vanguard Group Inc | 2023-12-31 | 18.2 K |
Enveric Biosciences Historical Income Statement
Enveric Biosciences Income Statement is one of the three primary financial statements used for reporting Enveric's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Enveric Biosciences revenue and expense. Enveric Biosciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Enveric Biosciences' Total Operating Expenses is projected to increase significantly based on the last few years of reporting. The current year's Income Tax Expense is expected to grow to about 30.4 K, whereas Depreciation And Amortization is forecasted to decline to about 387.6 K. View More FundamentalsEnveric Stock Against Markets
Picking the right benchmark for Enveric Biosciences stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Enveric Biosciences stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Enveric Biosciences is critical whether you are bullish or bearish towards Enveric Biosciences at a given time. Please also check how Enveric Biosciences' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Enveric Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Enveric Biosciences Corporate Management
Elected by the shareholders, the Enveric Biosciences' board of directors comprises two types of representatives: Enveric Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Enveric. The board's role is to monitor Enveric Biosciences' management team and ensure that shareholders' interests are well served. Enveric Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Enveric Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph Tucker | CEO Director | Profile | |
| Ibrahim MD | Chief Officer | Profile | |
| MBA IV | Interim Officer | Profile | |
| Peter Facchini | Chief Officer | Profile | |
| Avani Kanubaddi | Pres COO | Profile | |
| Kevin CPA | Chief Officer | Profile |
How to buy Enveric Stock?
Before investing in Enveric Biosciences, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Enveric Biosciences. To buy Enveric Biosciences stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Enveric Biosciences. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Enveric Biosciences stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Enveric Biosciences stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Enveric Biosciences stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Enveric Biosciences, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Enveric Stock please use our How to Invest in Enveric Biosciences guide.
Already Invested in Enveric Biosciences?
The danger of trading Enveric Biosciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Enveric Biosciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Enveric Biosciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Enveric Biosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Enveric Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enveric Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enveric Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enveric Biosciences Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enveric Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade Enveric Stock refer to our How to Trade Enveric Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Enveric Stock analysis
When running Enveric Biosciences' price analysis, check to measure Enveric Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enveric Biosciences is operating at the current time. Most of Enveric Biosciences' value examination focuses on studying past and present price action to predict the probability of Enveric Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enveric Biosciences' price. Additionally, you may evaluate how the addition of Enveric Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Enveric Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enveric Biosciences. If investors know Enveric will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enveric Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.09) | Revenue Per Share 37.678 | Quarterly Revenue Growth (0.07) | Return On Assets (0.86) | Return On Equity (1.97) |
The market value of Enveric Biosciences is measured differently than its book value, which is the value of Enveric that is recorded on the company's balance sheet. Investors also form their own opinion of Enveric Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Enveric Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enveric Biosciences' market value can be influenced by many factors that don't directly affect Enveric Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enveric Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enveric Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enveric Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.